Connect with us

Culture

Lawmakers Mourn Loss Of Charlotte Figi, Whose Story Inspired National CBD Movement And Helped Change Policies

Published

on

Advocates and lawmakers are mourning the loss of a young icon in the medical marijuana reform movement. Charlotte Figi, who showed the world how CBD can treat severe epilepsy, passed away on Tuesday at the age of 13 due to complications from a likely coronavirus infection.

Across social media, people are sending their support to the Figi family and sharing anecdotes about how Charlotte’s battle against Dravet syndrome—and the success she demonstrated in treating it with the cannabis compound—changed hearts and minds. Her impact has been felt across state legislatures and in Congress, where her story was often told as a clear example of why laws prohibiting access to cannabidiol needed to change.

The domino effect Charlotte’s story helped set off—with states, particularly conservative ones, passing modest reform bills for CBD access—paved the path for a successful congressional rider that ended up protecting more far-reaching medical cannabis programs across the U.S., advocates say.

Rep. Matt Gaetz (R-FL), who has become one of the leading GOP champions for broad marijuana reform on Capitol Hill, said he was personally influenced by Charlotte and, as a state lawmaker in 2014, her story motivated him to support legislation to reform Florida’s medical cannabis policies.

“Charlotte lived a life of tremendous significance. Her story inspired me to completely change my views on medical cannabis and successfully pass legislation so that patients could get help in Florida,” the congressman said. “I’m so sad she is gone, but the movement she has ignited will live forever.”

Sen. Cory Gardner (R-CO), another top marijuana reform advocate who has raised the issue directly with President Trump on several occasions, wrote that Charlotte “made a positive and everlasting change in the world by the age of 13, and her inspirational courage will always be remembered.”

“Charlotte changed the way the nation thinks about CBD through her grace and advocacy,” he said. “We should honor her by fixing our federal cannabis laws as soon as possible.”

Florida state Rep. Rob Bradley (R) agreed with the sentiment, writing that “Charlotte Figi was a bright, beautiful light that changed how our state and country views cannabis. I am saddened to hear that this sweet soul has left us.”

In Illinois, state Rep. Bob Morgan (D) said Charlotte, who is the namesake of one of the most well-known CBD brands, Charlotte’s Web, “singlehandedly transformed how the world viewed medical cannabis and children with epilepsy.”

“She suffered so much so that others would not have to,” he said. “May her memory be a blessing.”

Pennsylvania state Sen. Daylin Leach (D) also said Charlotte “inspired me to get involved in the cannabis movement” and “showed the world that Cannabis is medicine and the trail she blazed has helped millions.”

“The world lost a fighter,” Missouri Attorney General Eric Schmitt, who previously advocated for CBD reform as a state senator, said. “Charlotte Figi-who helped inspire passage of CBD Oil legislation for epilepsy treatment nationwide-passed away. I worked w/her mom/others in 14 in MO. My speech in the Senate was a tribute to her, June Jesse, my son & many others.”

Beyond championing a successful CBD bill in Florida, Charlotte’s family also captivated national audiences and became a household name in the reform movement. Her story was featured on a popular CNN documentary, “Weed,” hosted by Sanjay Gupta, that introduced people from diverging political ideologies to an issue that’s since become a focus of legislation across the country.

A bipartisan congressional bill named after her—the Charlotte’s Web Medical Access Act—was first introduced in 2015.

But while that standalone legislation didn’t advance, the growing number of state-level policy changes that were inspired by Charlotte and other young patients could help to explain why Congress, including members who oppose legalization, has consistently supported a budget rider that prohibits the Justice Department from interfering in state-legal medical cannabis programs. It was first approved in 2014—after repeatedly failing on the House floor—and has been renewed each year since.

With CBD-only states included on an enumerated list of those that would be protected from legal action, it became increasingly difficult for lawmakers to defend voting against a measure to prevent federal harassment of their own constituents. Support from more conservative-minded Democrats and a handful of Republicans, including those from states that had recently enacted or were debating their own CBD laws, allowed the amendment to narrowly advance for the first time when it had been handily defeated two years earlier.

Alabama, Florida, Iowa, Kentucky and South Carolina stand out as examples of states where cannabis reform came online between those votes and where support for the measure also increased among their congressional delegations.

The measure as approved by Congress and first signed into law law President Obama, has given explicit protection from federal prosecution not just to people complying with limited CBD-focused state laws but also medical cannabis growers, processors and retailers in states with more robust policies such as California and Colorado (though it does not protect recreational marijuana businesses or consumers).

“Charlotte Figi personalized this issue in a way that few others have, and her story humanized the medical cannabis fight to such a degree that many politicians could no longer ignore it,” Paul Armentano, deputy director of NORML, told Marijuana Moment. “There is little doubt that Charlotte’s story, arguably more than any other, paved the way for politicians in several southern and midwestern states to finally move forward to recognize the need for CBD, and in some cases, whole-plant cannabis access.”

Don Murphy, director of federal policies for the Marijuana Policy Project, said even opponents of cannabis legalization “can’t say ‘no’ to young mothers pushing sick kids in strollers,” referencing the many other patient advocates who helped usher the reform to victory.

“There’s no doubt it helped move the debate in our direction,” he said. “Truth is, I was once told that CBD hurt our effort [for broader reform]. I don’t think so.”

A person writing on behalf of the family on Tuesday said that “Charlotte is no longer suffering” and will be forever seizure-free.

CBD Prescription Drug Is No Longer A Federally Controlled Substance, DEA Says

Image element courtesy of Paige Figi.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Culture

Dr. Oz Claims DEA And FDA Blame Each Other For Keeping Marijuana Illegal

Published

on

According to celebrity doctor Mehmet Oz—or Dr. Oz—representatives from the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) have each told him they’re on board with legalizing marijuana. And the agencies blame each other for blocking efforts to end prohibition.

In a recent interview, Oz was asked about his professional opinion on cannabis. The host of the popular daytime program of his namesake called marijuana “one of the most underused tools in America” and went on to say that he’s had conversations with individuals from both DEA and FDA who generally share his views about the plant.

“We ought to completely change our policy on marijuana. It absolutely works,” he told interviewer Fatman Scoop, adding that another daytime TV host Montel Williams, who has multiple sclerosis, convinced him of the medical utility of cannabis. “Now I’ve seen this helping people with sleep issues, with pain issues for sure, and a lot of people who have serious medical problems getting relief—and here’s the thing, you can’t die from it. I’m unaware of any case when anyone has overdosed.”

“It’s a lot safer than alcohol. It’s safer than narcotics. It ought to be used more widely and we can’t even study it that easily because of the way it’s regulated,” he said. “You know what, I called the DEA—they said, ‘we don’t want this to be illegal. Your government ought to change that. But we got to enforce the law.’ I call the FDA that regulates the drugs, they say, ‘we think it ought to be used, but until the DEA says it’s allowed, we can’t let people prescribe it everywhere.”

While Oz didn’t disclose specifics about his conversations, such as who he spoke to or when the phone calls happened, it is the case that federal marijuana reform outside of Congress falls largely within the jurisdictions of both agencies. And DEA has denied multiple rescheduling requests, justifying the inaction by stating that FDA has determined that cannabis doesn’t have proven medical value and carries a risk of abuse.

Oz, who previously asserted that marijuana could represent a tool to combat the opioid epidemic and has made other public comments about the plant’s therapeutic potential, said “I’m hoping the federal government at some point—someone’s going to say, ‘come on, this is a farce, open it up for the entire country.’ That way, the right people can begin to prescribe it.”

Although Oz advocate for marijuana reform, he also clarified earlier this year that, despite rumors, he is not involved in a CBD company that falsely attributed an endorsement to him.

“I have never smoked pot in my life, never gotten high, and I only bring that up because I’m not someone who’s saying this because I personally would use it,” he said in this latest interview. “I just as a doctor think it make sense.”

White House Completes Review Of CBD Guidance From FDA

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

Don’t Drive High On Marijuana Even If You’re Being Chased By An Axe Murderer, Federal PSA Says

Published

on

The latest push by the federal government to deter marijuana-impaired driving is coming to TV, radio and the web. Its message? Even if you’re being chased by an axe-wielding psychopath, it’s not worth driving high.

The ad, a partnership between the National Highway Traffic Safety Administration (NHTSA) and the Ad Council, is the first TV spot developed by Vox Creative, the advertising arm of Vox Media. In it, two men run for their lives from a would-be murderer, dodging axe blows while reciting reasons not to drive stoned.

The men ultimately find a vehicle to escape the scene, but the driver pauses before he turns the key in the ignition. “Wait wait wait,” he says. “I can’t drive. I’m high.”

(Don’t worry. The two would-be murder victims swap seats and end up getting away safely while the sober one mans the wheel.)

“The rules around marijuana use can be confusing. But when it comes to marijuana use and driving, all you need to remember is one rule: Driving impaired is illegal everywhere.”

The Ad Council campaign also includes radio and online advertisements. A 30-second version of the video will run on TV, while a longer, 80-second version (embedded above) will reportedly run on Vox.com and the brand’s ad marketplace, Concert.

“Many marijuana users don’t see a problem with driving after use, but research shows marijuana can slow reaction time, impair judgment of distance, and decrease coordination – all skills necessary for the safe operating of a vehicle,” the Ad Council said in a statement accompanying the new video. “Our campaign targets young men aged 18 to 35, many of whom reject the common stereotypes of marijuana users.”

Stereotypes or no, the campaign reminds consumers that driving under the influence of marijuana is illegal in all 50 U.S. states—even if cannabis itself is legal in a growing number of them.

“The rules around marijuana use can be confusing,” its website says. “But when it comes to marijuana use and driving, all you need to remember is one rule: Driving impaired is illegal everywhere.”

Beyond the video and radio ads, the awareness push also includes a number of self-aware signage with messages such as “This is an ad that says you shouldn’t drive high.”

"This is an ad that says you shouldn't drive high" poster

Courtesy of the Ad Council, NHTSA and Vox Creative

As more states have considered legalizing marijuana in recent years, highway safety has become a major focus. Opponents often contend that increased roadway risks themselves are enough to tap the brakes on reform.

In a typical example, the Washington Post’s editorial board in 2014 came out against legalization in Washington, D.C., citing “negative consequences, including increased instances of impaired driving.”

While being impaired no doubt increases drivers’ danger to themselves and others, some critics have complained that the risks of marijuana-impaired driving have been overblown, used as a fear tactic to chill cannabis reform. They argue that research on cannabis and driving is still thin and conflicted, and that the drug’s effect on driving pales in comparison to alcohol and some prescription drugs.

A report commissioned by Congress and published last year cast doubt on the dire warnings of THC-impaired driving. “Although laboratory studies have shown that marijuana consumption can affect a person’s response times and motor performance, studies of the impact of marijuana consumption on a driver’s risk of being involved as a crash have produced conflicting results, with some studies finding little or no increased risk of a crash from marijuana usage,” the Congressional Research Service wrote.

NHTSA, part of the Department of Transportation, has long acknowledged that THC concentration in drivers’ blood levels does not correlate with driver impairment. (The campaign even includes that fact on its website. “Unlike alcohol, there is no correlation between rising THC level and driver impairment,” it says. But that doesn’t mean it’s safe to drive high: “Some research studies have found that peak performance deficits are observed long after peak THC level occurs.”)

The lack of a clear correlation between marijuana and impaired driving has been enough to push some jurisdictions to reconsider per-se THC limits, under which drivers can be charged with a DUI based on the amount of THC in their blood regardless of any evidence of actual impairment.

In Pennsylvania, lawmakers last month introduced a bill that would force police instead to prove impairment. The legislation would exempt medical marijuana patients from the state’s existing DUI law, and police would instead have to demonstrate that a patient’s driving was actually impaired by the drug.

Meanwhile, Congress is taking steps to require states to study the impacts of marijuana-impaired driving. Legislation introduced last month would force states that have legalized cannabis, and only those states, to consider how to educate and discourage people from driving while high. Advocates have questioned that approach, noting that while impaired driving is an important issue, it’s not limited to states with legal cannabis.

Earlier this month, the U.S. House of Representatives voted to take a number of steps related to marijuana-impaired driving, including directing federal agencies to prepare a report on “the establishment of a national clearinghouse for purposes of facilitating research on marijuana-impaired driving.” Rep. Peter DeFazio (D-OR), a sponsor of the bill, also wants the report to outline how researchers in states that haven’t legalized marijuana can still access cannabis from dispensaries to study the drug’s effects on driving.

Congress rejected another amendment, however, that would have required NHTSA “carry out a collaborative research effort to study the effect that marijuana has on driving and research ways to detect and reduce incidences of driving under the influences of marijuana.”

Colorado’s Marijuana Legalization Law Decreases Crime In Neighboring States, Study Finds

Photo courtesy of Carlos Gracia

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

HBO Teams Up With Marijuana Companies To Sell THC Gummies Promoting New TV Series

Published

on

HBO is partnering up with major marijuana businesses to market a line of promotional cannabis edible gummies meant to bring attention to an animated series premiering next week, the entertainment giant announced on Monday.

The 10mg THC gummies are made by the marijuana company Kanha and will be available at select California dispensaries as well as via delivery from Eaze. Each blend was developed to produces effects the network says reflect the personalities of the four main characters from “Close Enough,” which will be streaming on HBO Max starting July 9.

Via HBO.

“It has been so thrilling for my team and I to create a campaign that feels so authentic to Close Enough,” Peter Sherman, senior vice president of program marketing at HBO Max, said in a press release. “When crafting any campaign, our aim is always to create an experience for the audience that feels genuine and exciting, and this partnership with Kanha hits the nail on the head. We’re so excited about this one and we can’t wait to see how fans react.”

What’s interesting about the promotion—beside the fact that a major, international media company is working with the cannabis industry—is that the series doesn’t even seem to have much to do with marijuana. It’s an adult-themed comedic animated show that touches on themes like raising children and navigating careers. The trailer doesn’t even mention cannabis.

So instead, it seems HBO is simply embracing the culture of consuming marijuana while enjoying TV.

“Kanha’s partnership with HBO Max is an exciting opportunity to showcase our delicious, award-winning gummies to a brand new audience,” Cameron Clarke, CEO of the parent company Sunderstorm, said. “We can’t think of a more playful, fun collaboration to announce to our fiercely loyal fans. We’re thrilled to partner with one of entertainment’s biggest media giants to help bring the adult characters in their new show to life through our gummy flavors and profiles.”

Here’s how HBO described each of the flavors that are based on the show’s characters: 

JOSH: Cool dad, husband, and future world-famous video-game designer, Josh likes to chill with his Indica Strawberry Gummies.

EMILY: Emily is logical, organized, a planner — everything her husband Josh is not. She’s a loving mother and a strong working woman who tries to have it all. Busy mom Emily gets it done with her Sativa Pineapple Gummies.

ALEX: Alex is Josh’s neurotic best friend from high school. He lives in the walk-in closet of the apartment he shares with Josh, Emily, Candice, and Bridgette (his ex-wife, but it’s not a big deal). When Alex wants to get lost in thought, he stays cool and carries on with his Hybrid Watermelon Gummies.

BRIDGETTE: Bridgette is a glamorous social media influencer — at least in her mind. ‘Working’ is more of a hobby she squeezes in between partying. Bridgette stays on top of partying and her social game with her 1:1 Pink Lemonade Gummies.

Eaze CEO Ro Choy said that the partnership with HBO Max “is so exciting and it’s a great way to connect with audiences.”

“Eaze is all about high product standards and the best value for customers, and we’re pleased to align with one of the biggest and most respected names in entertainment,” he said.

The promotion begins on Monday and extends through the end of July, or until supplies run out. There are 20 California dispensaries that carry the products, and Eaze will offer them through deliveries in Los Angeles, San Francisco and San Diego.

Oregon Psilocybin Measure Has Enough Signatures For November Ballot, Activists Say

Photo courtesy of Flickr/JasonParis.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!